(Q70802980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

A. Theodorou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

W. Gommeren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

A. Clow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

J. Leysen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

P. Jenner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

C. D. Marsden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7242249

31 March 2024

language of work or name

English

0 references

publication date

1 April 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

6 April 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7242249

full work available at URL

31 March 2024

https://api.elsevier.com/content/article/PII:0024320581903179?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

https://api.elsevier.com/content/article/PII:0024320581903179?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

31 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

1621-1627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

14 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Serotonergic component of neuroleptic receptors

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Stereospecific in vitro binding of [3H]dexetimide to brain muscarinic receptors

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Histamine H1-receptors in brain labeled with 3H-mepyramine

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist states

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Muscimol binding in rat brain: Association with synaptic GABA receptors

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

The pharmacology of tardive dyskinesias

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

3H-Spiperone binding in normal and schizophrenic post-mortem human brain

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Increased dopamine-receptor sensitivity in schizophrenia

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(81)90317-9

31 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7242249%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference